Clinical Trial Update: PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and Rosuvastatin [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study comparing a fixed-dose combination of telmisartan and rosuvastatin to taking the two drugs separately in individuals with dyslip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertension

Drugs mentioned

• Rosuvastatin (rosuvastatin)
• Telmisartan (Telmisartan)
• Telmisartan/Rosuvastatin (telmisartan/rosuvastatin)

Snippet

Sponsor: Yuhan Corporation | Conditions: Dyslipidemia & Hypertension | Phase 1 | Status: COMPLETED